Biggest changeRevenues and other information for the periods presented are reflected in the tables below for our reportable segments: Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues: O&P-Americas segment $ 11,533 $ 11,280 O&P-EAI segment 10,867 10,479 I&D segment 10,424 11,086 APS segment 3,634 3,698 Refining segment 8,559 9,714 Technology segment 671 663 Other, including intersegment eliminations (5,386) (5,813) Total $ 40,302 $ 41,107 Operating income (loss): O&P-Americas segment $ 1,805 $ 1,665 O&P-EAI segment (1,008) (160) I&D segment 951 1,262 APS segment (48) (261) Refining segment (213) 221 Technology segment 338 334 Other, including intersegment eliminations (8) (8) Total $ 1,817 $ 3,053 38 Table of Conten ts Year Ended December 31, Millions of dollars 2024 2023 Depreciation and amortization: O&P-Americas segment $ 619 $ 587 O&P-EAI segment 220 207 I&D segment 401 443 APS segment 90 98 Refining segment 150 158 Technology segment 42 41 Total $ 1,522 $ 1,534 Income (loss) from equity investments: O&P-Americas segment $ 13 $ 49 O&P-EAI segment (217) (55) I&D segment (13) (13) APS segment — (1) Total $ (217) $ (20) Impairments: O&P-Americas segment $ — $ 25 O&P-EAI segment 892 38 I&D segment 2 192 APS segment 55 252 Refining segment — 11 Total $ 949 $ 518 Gain on sale of business: I&D segment $ 284 $ — Total $ 284 $ — Other income (expense), net: O&P-Americas segment $ 8 $ 2 O&P-EAI segment 14 (1) I&D segment 41 (13) APS segment 12 2 Refining segment 3 — Technology segment (1) — Other, including intersegment eliminations (27) (48) Total $ 50 $ (58) EBITDA: O&P-Americas segment $ 2,445 $ 2,303 O&P-EAI segment (991) (9) I&D segment 1,664 1,679 APS segment 54 (162) Refining segment (60) 379 Technology segment 379 375 Other, including intersegment eliminations (35) (56) Total $ 3,456 $ 4,509 39 Table of Conten ts Olefins and Polyolefins-Americas Segment Overview —EBITDA increased in 2024 relative to 2023 primarily due to improved olefins margins, partially offset by lower polymer margins.
Biggest changeRevenues and other information for the periods presented are reflected in the tables below for our reportable segments: Year Ended December 31, Millions of dollars 2025 2024 Sales and other operating revenues: O&P-Americas segment $ 9,801 $ 11,533 O&P-EAI segment 10,227 10,867 I&D segment 9,069 10,424 APS segment 3,472 3,634 Technology segment 549 671 Other, including intersegment eliminations (2,965) (3,735) Total $ 30,153 $ 33,394 Operating income (loss): O&P-Americas segment $ 441 $ 1,805 O&P-EAI segment (684) (1,008) I&D segment 428 951 APS segment (743) (48) Technology segment 137 338 Other, including intersegment eliminations 1 (120) Total $ (420) $ 1,918 39 Table of Contents Year Ended December 31, Millions of dollars 2025 2024 Depreciation and amortization: O&P-Americas segment $ 652 $ 619 O&P-EAI segment 203 220 I&D segment 409 401 APS segment 83 90 Technology segment 43 42 Total $ 1,390 $ 1,372 Income (loss) from equity investments: O&P-Americas segment $ 37 $ 13 O&P-EAI segment (52) (217) I&D segment 3 (13) Total $ (12) $ (217) Impairments: O&P-Americas segment $ 9 $ — O&P-EAI segment 460 892 I&D segment — 2 APS segment 782 55 Total $ 1,251 $ 949 Gain (loss) on sale of business: I&D segment $ — $ 284 APS segment (6) — Total $ (6) $ 284 Other income (expense), net: O&P-Americas segment $ 14 $ 8 O&P-EAI segment 76 14 I&D segment 38 41 APS segment 15 12 Technology segment — (1) Other, including intersegment eliminations (30) (27) Total $ 113 $ 47 EBITDA: O&P-Americas segment $ 1,144 $ 2,445 O&P-EAI segment (457) (991) I&D segment 878 1,664 APS segment (651) 54 Technology segment 180 379 Discontinued operations 61 56 Other, including intersegment eliminations (29) (147) Total $ 1,126 $ 3,460 40 Table of Contents Olefins and Polyolefins-Americas Segment Overview —EBITDA decreased in 2025 relative to 2024 primarily due to lower margins.
The degree of influence of a particular benchmark may vary from period to period, as the composition of the dollar value LIFO pools change. An actual valuation of inventory under the LIFO method is performed at the end of each year based on the inventory levels and costs at that time.
The degree of influence of a particular benchmark may vary from period to period, as the composition of the dollar-value LIFO pools change. An actual valuation of inventory under the LIFO method is performed at the end of each year based on inventory levels and costs at that time.
Ethylene Raw Materials —Ethylene and its co-products are produced from two major raw material groups: • natural gas liquids (“NGLs”), principally ethane and propane, the prices of which are generally affected by natural gas prices; and • crude oil-based liquids (“liquids” or “heavy liquids”), including naphtha, condensates and gas oils, the prices of which are generally related to crude oil prices.
Ethylene Raw Materials —Ethylene and its co-products are produced from two major raw material groups: • natural gas liquids, principally ethane and propane, the prices of which are generally affected by natural gas prices; and • crude oil-based liquids (“liquids” or “heavy liquids”), including naphtha, condensates and gas oils, the prices of which are generally related to crude oil prices.
Accruals for Taxes Based on Income —The determination of our provision for income taxes and the calculation of our tax benefits and liabilities is subject to management’s estimates and judgments due to the complexity of the tax laws and regulations in the tax jurisdictions in which we operate. Uncertainties exist with respect to interpretation of these complex laws and regulations.
Accruals for Taxes Based on Income —The determination of our provision for income taxes and the calculation of our tax benefits and liabilities is subject to our estimates and judgments due to the complexity of the tax laws and regulations in the tax jurisdictions in which we operate. Uncertainties exist with respect to interpretation of these complex laws and regulations.
Long-Lived Assets Impairment Assessment —The need to test for impairment can be based on several indicators, including a significant reduction in prices of or demand for products produced, a weakened outlook for profitability, a significant reduction in margins, an expectation that a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life, other changes to contracts or changes in the regulatory environment.
The need to test for impairment can be based on several indicators, including a significant reduction in prices of or demand for products produced, a weakened outlook for profitability, a significant reduction in margins, an expectation that a long-lived asset will be sold or otherwise disposed of significantly before the end of its previously estimated useful life, other changes to contracts or changes in the regulatory environment.
We also have purchase obligations under take-or-pay agreements which require us to either buy and take delivery of a minimum quantity of goods or to pay for any shortfall. These arrangements largely relate to product off-take agreements with a joint venture located in Poland . No material shortfall was paid for quantities not taken under these contracts in 2024.
We also have purchase obligations under take-or-pay agreements which require us to either buy and take delivery of a minimum quantity of goods or to pay for any shortfall. These arrangements largely relate to product off-take agreements with a joint venture located in Poland . No material shortfall was paid for quantities not taken under these contracts in 2025.
Upon settlement of these foreign currency contracts, which were designated as cash flow hedges, we paid €784 million ($835 million at the expiry spot rate) to our counterparties and received $849 million from our counterparties. For additional information related to our swaps and currency contracts, see Note 13 to the Consolidated Financial Statements.
Upon settlement of these foreign currency contracts, which were designated as cash flow hedges, we paid €784 million ($835 million at the expiry spot rate) to our counterparties and received $849 million from our counterparties. For additional information related to our swaps and currency contracts, see Note 15 to the Consolidated Financial Statements.
These purchase arrangements include provisions which state minimum purchase quantities or fixed-fees; however, in the event we do not take the contractual minimum volumes, we are obligated to compensate the vendor only for any resulting economic losses they suffer. No material fees were paid to vendors for such losses in 2024.
These purchase arrangements include provisions which state minimum purchase quantities or fixed-fees; however, in the event we do not take the contractual minimum volumes, we are obligated to compensate the vendor only for any resulting economic losses they suffer. No material fees were paid to vendors for such losses in 2025.
The actual rate of return on plan assets may differ from the expected rate due to the volatility normally experienced in capital markets. Management’s goal is to manage the investments over the long term to achieve optimal returns with an acceptable level of risk and volatility.
The actual rate of return on plan assets may differ from the expected rate due to the volatility normally experienced in capital markets. Our goal is to manage the investments over the long term to achieve optimal returns with an acceptable level of risk and volatility.
We had total unused availability under our credit facilities of $4,650 million at December 31, 2024, which included the following: • $3,750 million under our $3,750 million Senior Revolving Credit Facility. This facility backs our $2,500 million commercial paper program.
We had total unused availability under our credit facilities of $4,650 million at December 31, 2025, which included the following: • $3,750 million under our $3,750 million Senior Revolving Credit Facility. This facility backs our $2,500 million commercial paper program.
Availability under this facility is net of outstanding borrowings, outstanding letters of credit provided under the facility and notes issued under our commercial paper program. At December 31, 2024, we had no outstanding commercial paper and no borrowings or letters of credit outstanding under this facility; and • $900 million under our $900 million U.S. Receivables Facility.
Availability under this facility is net of outstanding borrowings, outstanding letters of credit provided under the facility and notes issued under our commercial paper program. At December 31, 2025, we had no outstanding commercial paper and no borrowings or letters of credit outstanding under this facility; and • $900 million under our $900 million U.S. Receivables Facility.
The following table reflects the sensitivity of the benefit obligations and the net periodic benefit costs of our pension plans to changes in the actuarial assumptions: Effects on Benefit Obligations in 2024 Effects on Net Periodic Pension Costs in 2025 Millions of dollars U.S. Non-U.S. U.S. Non-U.S.
The following table reflects the sensitivity of the benefit obligations and the net periodic benefit costs of our pension plans to changes in the actuarial assumptions: Effects on Benefit Obligations in 2025 Effects on Net Periodic Pension Costs in 2026 Millions of dollars U.S. Non-U.S. U.S. Non-U.S.
We have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.
We first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value.
Accordingly, interim LIFO calculations are based on our estimates of expected inventory levels and costs at the end of the year. LIFO value is measured at the total pool level.
Accordingly, interim LIFO calculations are based on our estimate of expected inventory levels and costs at the end of the year. LIFO value is measured at the total pool level.
Management’s estimate of fair value of an investment is based on the income approach and/or market approach. For the income approach, the fair value is typically based on the present value of expected future cash flows using discount rates believed to be consistent with those used by principal market participants.
Estimates of fair value of an investment is based on the income approach and/or market approach. For the income approach, the fair value is typically based on the present value of expected future cash flows using discount rates believed to be consistent with those used by principal market participants.
Share Repurchases In May 2024, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 24, 2025, which superseded any prior repurchase authorizations. Our share repurchase authorization does not have a stated dollar amount, and purchases may be made through open market purchases, private market transactions or other structured transactions.
Share Repurchases In May 2025, our shareholders approved a proposal to authorize us to repurchase up to 34.0 million ordinary shares, through November 23, 2026, which superseded any prior repurchase authorizations. Our share repurchase authorization does not have a stated dollar amount, and purchases may be made through open market purchases, private market transactions or other structured transactions.
When determining whether a decline in value is other than temporary, management considers factors such as the duration and extent of the decline, the investee’s financial condition and near-term prospects, and our ability and intention to retain our investment for a period that will be sufficient to allow for any anticipated recovery in the value of the investment.
When determining whether a decline in value is other than temporary, we consider factors such as the duration and extent of the decline, the investee’s financial condition and near-term prospects, and our ability and intention to retain our investment for a period that will be sufficient to allow for any anticipated recovery in the value of the investment.
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2023 which was filed with the Securities and Exchange Commission on February 22, 2024 of which Item 7 is incorporated herein by reference.
Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the Securities and Exchange Commission on February 27, 2025, of which Item 7 is incorporated herein by reference.
If the carrying value of the reporting unit including goodwill exceeds its fair value, an impairment charge equal to the excess would be recognized, up to a maximum amount of goodwill allocated to that reporting unit.
If the carrying value of the reporting unit, including goodwill, exceeds its fair value, an impairment charge equal to the excess is recognized, up to a maximum amount of goodwill allocated to that reporting unit.
In the fourth quarter of 2024, we performed a qualitative impairment assessment of our reporting units, which indicated that it was more likely than not that the fair value of our reporting units was greater than their carrying value including goodwill. Accordingly, a quantitative goodwill impairment test was not required.
In the fourth quarter of 2025, we performed a qualitative impairment assessment of our reporting units, which indicated that it was more likely than not that the fair value of our reporting units exceeded their carrying value, including goodwill. Accordingly, a quantitative goodwill impairment test was not required.
Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly. Ethane made up approximately 75% and 70% of the raw materials used in our North American crackers in 2024 and 2023, respectively.
Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly. Ethane made up approximately 75% to 80% of the raw materials used in our North American crackers in 2025 and 2024.
If the sum of the undiscounted estimated pre-tax cash flows for an asset group is less than the asset group’s carrying value, fair value is calculated for the asset group using an income approach or a market approach when appropriate, and the carrying value is written down to the calculated fair value.
If the sum of the undiscounted estimated pre-tax cash flows is less than the carrying value of an asset group, fair value is calculated using an income approach or a market approach, and the carrying value is written down to the calculated fair value.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, management offsets revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, we offset revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, management offsets revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
In calculating the impact of margin and volume on EBITDA, consistent with industry practice, we offset revenues and volumes related to ethylene co-products against the cost to produce ethylene. Volume and price impacts of ethylene co-products are reported in margin.
The weighted average expected long-term rate of return on assets in our non-U.S. plans of 4.14% is based on expectations and asset allocations that vary by region. The asset allocations are summarized in Note 14 to the Consolidated Financial Statements.
The weighted average expected long-term rate of return on assets in our non-U.S. plans of 3.44% is based on expectations and asset allocations that vary by region. The asset allocations are summarized in Note 16 to the Consolidated Financial Statements.
For more information regarding our debt arrangements, lease obligations, pension and other post-retirement benefits and income taxes, see Notes 11, 12, 14 and 16 to the Consolidated Financial Statements, respectively.
For more information regarding our debt arrangements, lease obligations, pension and other post-retirement benefits and income taxes, see Notes 13, 14, 16 and 18 to the Consolidated Financial Statements, respectively.
Investing Activities —Capital expenditures in 2024 totaled $1,839 million compared to $1,531 million in 2023, of which approximately 75% and 70%, respectively, support sustaining maintenance such as turnaround activities at several sites as well as other plant Health, Safety and Environmental projects. The remaining expenditures support profit-generating growth projects.
Investing Activities —Capital expenditures in 2025 totaled $1,878 million compared to $1,839 million in 2024, of which approximately 65% and 75%, respectively, support sustaining maintenance such as turnaround activities at several sites as well as other plant health, safety and environmental projects. The remaining expenditures support profit-generating growth projects.
The lower effective tax rate for 2024 was primarily attributable to changes in earnings in countries with varying statutory tax rates, largely attributable to fourth quarter non-cash impairments decreasing the effective tax rate by 5.5% in comparison to 2023.
The lower effective tax rate for 2024 was primarily attributable to changes in earnings in countries with varying statutory tax rates, largely attributable to fourth quarter non-cash impairments decreasing the effective tax rate by 4.7 percentage points in comparison to 2023.
The following table sets forth selected financial information for the APS segment including Loss from equity investments, which is a component of EBITDA.
The following table sets forth selected financial information for the I&D segment including Income (loss) from equity investments, which is a component of EBITDA.
During 2023, we recognized non-cash impairment charges of $518 million, primarily consisting of a goodwill impairment charge of $252 million in our APS segment and an impairment charge of $192 million related to our European PO joint venture recognized in our I&D segment. See Notes 7, 8 and 20 to the Consolidated Financial Statements for additional information regarding impairment charges.
During 2023, we recognized non-cash impairment charges of $507 million, primarily consisting of a $252 million goodwill impairment charge in our APS segment and a $192 million impairment charge related to our European PO Joint Venture, recognized in our I&D segment. See Notes 9 and 10 to the Consolidated Financial Statements for additional information regarding impairment charges.
Assuming that contractual minimum volumes are purchased at contract prices as of December 31, 2024, these commitments represent approximately 15% of our annual Cost of sales with a weighted average remaining term of 8 years.
Assuming that contractual minimum volumes are purchased at contract prices as of December 31, 2025, these commitments represent approximately 20% of our annual Cost of sales with a weighted average remaining term of 6 years.
There was a further decrease in the effective tax rate of 1.7% related to fluctuations in foreign exchange gains and losses, partially offset by an increase in the effective tax rate of 2.6% related to reduced exempt income in 2024. For additional information, see Note 16 to the Consolidated Financial Statements.
There was a further decrease in the effective tax rate of 1.8 percentage points related to fluctuations in foreign exchange gains and losses, partially offset by an increase in the effective tax rate of 2.5 percentage points related to reduced exempt income in 2024. For additional information, see Note 18 to the Consolidated Financial Statements.
Ethylene Raw Materials —In Europe, naphtha is the primary raw material for our ethylene production and represented approximately 60% and 65% of the raw materials used in 2024 and 2023, respectively. 40 Table of Conten ts The following table sets forth selected financial information for the O&P-EAI segment including Loss from equity investments, which is a component of EBITDA.
Ethylene Raw Materials —In Europe, naphtha is the primary raw material for our ethylene production and represented approximately 70% and 60% of the raw materials used in 2025 and 2024, respectively. 41 Table of Contents The following table sets forth selected financial information for the O&P-EAI segment including Loss from equity investments, which is a component of EBITDA.
As of February 25, 2025, we had approximately 31.1 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders.
As of February 18, 2026, we had approximately 34.0 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders.
Comprehensive Income— Comprehensive income decreased by $706 million in 2024 compared to 2023, primarily due to a decrease in net income. The activities from the remaining components of Comprehensive income are discussed below.
Comprehensive Income (Loss)— Comprehensive income (loss) decreased by $1,827 million in 2025 compared to 2024, primarily due to a decrease in net income (loss). The activities from the remaining components of Comprehensive income (loss) are discussed below.
Availability under this facility is subject to a borrowing base of eligible receivables, which is reduced by outstanding borrowings and letters of credit, if any. At December 31, 2024, we had no borrowings or letters of credit outstanding under this facility. In 2024, we amended some terms of our credit agreements.
Availability under this facility is subject to a borrowing base of eligible receivables, which is reduced by outstanding borrowings and letters of credit, if any. At December 31, 2025, we had no borrowings or letters of credit outstanding under this facility.
Schulman Inc. in 2018 and the tax effect of the differences between the tax and book basis of our assets and liabilities resulting from the revaluation of those assets and liabilities to fair value in connection with the Company’s emergence from bankruptcy and fresh-start accounting in 2010.
Schulman Inc. in 2018, as well as the tax effects of differences between the tax and book basis of our assets and liabilities, which resulted from the revaluation of those assets and liabilities to fair value in connection with the Company’s emergence from bankruptcy and the application of fresh-start accounting in 2010.
Impairments —During 2024, we recognized non-cash impairment charges of $949 million, primarily consisting of impairments of property, plant and equipment of $892 million in our O&P-EAI and APS segments.
Additionally, during 2025, we recognized other non-cash impairment charges of $69 million, primarily related to property, plant and equipment in our O&P-Americas and O&P-EAI segments. During 2024, we recognized non-cash impairment charges of $949 million, primarily consisting of $892 million of property, plant and equipment impairments in our O&P-EAI and APS segments.
Projected benefit obligations at December 31, 2024 $ 139 $ 52 $ — $ — Projected net periodic benefit costs in 2025 — — (1) 3 Discount rate increases by 100 basis points (10) (10) (1) (1) Discount rate decreases by 100 basis points 11 13 1 1 Additional information on the key assumptions underlying these benefit costs appears in Note 14 to the Consolidated Financial Statements.
Projected benefit obligations at December 31, 2025 $ 134 $ 55 $ — $ — Projected net periodic benefit costs in 2026 — — 1 3 Discount rate increases by 100 basis points (9) (10) (1) (1) Discount rate decreases by 100 basis points 10 13 1 1 Additional information on the key assumptions underlying these benefit costs appears in Note 16 to the Consolidated Financial Statements.
The discussion summarizing the significant factors affecting the results of operations and financial condition for the year ended December 31, 2022 and for the year ended December 31, 2023 compared to 2022 has been excluded from this Form 10-K and can be found in Part II, “Item 7.
The discussion summarizing the significant factors affecting the results of operations and financial condition for the year ended December 31, 2023 and for the year ended December 31, 2024 compared to 2023, except as impacted by the change for discontinued operations discussed above, has been excluded from this Form 10-K and can be found in Part II, “Item 7.
See Note 11 to the Consolidated Financial Statements for additional details. 45 Table of Conten ts At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures.
At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures.
The net periodic benefit cost of pension benefits included in expense is affected by the expected long-term rate of return on plan assets assumption. Investment returns that are recognized currently in net income represent the expected long-term rate of return on plan assets applied to a market-related value of plan assets, which is defined as the market value of assets.
Investment returns that are recognized currently in net income represent the expected long-term rate of return on plan assets applied to a market-related value of plan assets, which is defined as the market value of assets.
Crude oil and natural gas prices are subject to many factors, including changes in economic conditions. 47 Table of Conten ts Since our inventory consists of manufactured products derived from crude oil, natural gas, natural gas liquids and correlated materials, as well as the associated feedstocks and intermediate chemicals, our inventory market values are generally influenced by changes in the benchmark of crude oil and heavy liquid values and prices for manufactured finished goods.
The cost of raw materials, which represents a substantial portion of our operating expenses, and energy costs generally follow price trends for crude oil and natural gas which are subject to many factors, including changes in economic conditions. 47 Table of Contents Since our inventory consists of manufactured products derived from crude oil, natural gas, natural gas liquids and correlated materials, as well as the associated feedstocks and intermediate chemicals, our inventory market values are generally influenced by changes in the benchmark of crude oil and heavy liquid values and prices for manufactured finished goods.
Foreign currency translations decreased Comprehensive income by $242 million in 2024 compared to 2023, primarily due to the strengthening of the U.S. dollar relative to the euro in 2024, offset by the effective portion of our net investment hedges.
Foreign currency translations increased Comprehensive income (loss) by $368 million in 2025 compared to 2024, primarily due to the weakening of the U.S. dollar relative to the euro in 2025, partially offset by the effective portion of our net investment hedges.
If the qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, a quantitative test is required. We also have the option to proceed directly to the quantitative impairment test.
If the qualitative assessment indicates that it is more likely than not that the carrying value of a reporting unit exceeds its fair value, a quantitative test is required.
Financial derivatives designated as cash flow hedges, primarily our commodity swaps, led to an increase in Comprehensive income of $195 million in 2024 compared to 2023, reflecting commodity pricing volatility.
Financial derivatives designated as cash flow hedges, primarily our commodity swaps, led to a decrease in Comprehensive income (loss) of $137 million in 2025 compared to 2024, reflecting commodity pricing volatility.
Upon settlement of these foreign currency contracts, we paid €750 million ($820 million at the expiry spot rate) to our counterparties and received $903 million from our counterparties. Financing Activities —We made dividend payments totaling $1,720 million and $1,610 million, in 2024 and 2023, respectively.
Upon settlement of these foreign currency contracts, we paid €850 million ($921 million at the expiry spot rate) to our counterparties and received $967 million from our counterparties. 44 Table of Contents Financing Activities —We made dividend payments totaling $1,764 million and $1,720 million, in 2025 and 2024, respectively.
See Note 20 to the Consolidated Financial Statements for additional information regarding capital spending by segment. In 2024, we sold our EO&D business for $689 million and invested approximately $500 million to acquire a 35% stake in the National Petrochemical Industrial Company (“NATPET”) joint venture. See Notes 8 and 20 to the Consolidated Financial Statements for additional information.
See Note 22 to the Consolidated Financial Statements for additional information regarding capital spending by segment. In 2025, we received proceeds of $67 million upon the sale of excess European emission credits. In 2024, we sold our EO&D business for $689 million and invested approximately $500 million to acquire a 35% stake in the National Petrochemical Industrial Company joint venture.
The following table presents the reconciliation of Net Income to EBITDA for each of the periods presented: Year Ended December 31, Millions of dollars 2024 2023 Net income $ 1,367 $ 2,121 (Income) loss from discontinued operations, net of tax (4) 5 Income from continuing operations 1,363 2,126 Provision for income taxes 240 501 Depreciation and amortization 1,522 1,534 Interest expense, net 331 348 EBITDA $ 3,456 $ 4,509 Our continuing operations are managed through six reportable segments: O&P-Americas, O&P-EAI, I&D, APS, Refining and Technology.
The following table presents the reconciliation of Net income (loss) to EBITDA for each of the periods presented: Year Ended December 31, Millions of dollars 2025 2024 Net income (loss) $ (738) $ 1,367 Provision for income taxes 84 240 Depreciation and amortization 1,390 1,522 Interest expense, net 390 331 EBITDA $ 1,126 $ 3,460 Our continuing operations are managed through five reportable segments: O&P-Americas, O&P-EAI, I&D, APS and Technology.
Additionally, in 2024 and 2023, we made payments of $195 million and $211 million to repurchase outstanding ordinary shares, respectively. For additional information related to our share repurchases and dividend payments, see Note 18 to the Consolidated Financial Statements. In 2024, we issued $750 million of 5.5% guaranteed notes due 2034.
Additionally, in 2025 and 2024, we made payments of $201 million and $195 million to repurchase outstanding ordinary shares, respectively. For additional information related to our share repurchases and dividend payments, see Note 20 to the Consolidated Financial Statements. In 2025, we issued $500 million of 5.125% guaranteed notes due 2031 and $1,000 million of 5.875% guaranteed notes due 2036.
Projected benefit obligations at December 31, 2024 $ 1,232 $ 1,389 $ — $ — Projected net periodic pension costs in 2025 — — 59 54 Discount rate increases by 100 basis points (101) (176) (7) (5) Discount rate decreases by 100 basis points 120 205 9 7 The sensitivity of our post-retirement benefit plans obligations and net periodic benefit costs to changes in actuarial assumptions are reflected in the following table: Effects on Benefit Obligations in 2024 Effects on Net Periodic Benefit Costs in 2025 Millions of dollars U.S.
Projected benefit obligations at December 31, 2025 $ 1,168 $ 1,415 $ — $ — Projected net periodic pension costs in 2026 — — 50 54 Discount rate increases by 100 basis points (97) (167) (2) (5) Discount rate decreases by 100 basis points 114 192 12 9 50 Table of Contents The sensitivity of our post-retirement benefit plans obligations and net periodic benefit costs to changes in actuarial assumptions are reflected in the following table: Effects on Benefit Obligations in 2025 Effects on Net Periodic Benefit Costs in 2026 Millions of dollars U.S.
Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse. 51 Table of Conten ts We recognize future tax benefits to the extent that the realization of these benefits is more likely than not.
Deferred tax assets and liabilities are determined based on temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to reverse.
Our current provision for income taxes is impacted by the recognition and release of valuation allowances related to net deferred tax assets in certain jurisdictions.
We recognize future tax benefits to the extent that the realization of these benefits is more likely than not. Our current provision for income taxes is impacted by the recognition and release of valuation allowances related to net deferred tax assets in certain jurisdictions.
See Notes 13, 14 and 18 to the Consolidated Financial Statements for further discussions. 37 Table of Conten ts Segment Analysis We use earnings from continuing operations before interest, income taxes, and depreciation and amortization (“EBITDA”) as our measure of profitability for segment reporting purposes.
See Notes 15, 16 and 20 to the Consolidated Financial Statements for further discussions. 38 Table of Contents Segment Analysis We use net income (loss) before interest, income taxes, and depreciation and amortization (“EBITDA”) as our measure of profitability for segment reporting purposes.
The expected rate of return on plan assets is a longer-term rate and is expected to change less frequently than the current assumed discount rate, reflecting long-term market expectations, rather than current fluctuations in market conditions. 50 Table of Conten ts The weighted average expected long-term rate of return on assets in our U.S. plans of 7.25% is based on the average level of earnings that our independent pension investment advisor advised could be expected to be earned over time.
The weighted average expected long-term rate of return on assets in our U.S. plans of 7.25% is based on the average level of earnings that our independent pension investment advisor advised could be expected to be earned over time.
In 2024, foreign currency contracts with an aggregate notional value of €850 million expired. Upon settlement of these foreign currency contracts, we paid €850 million ($921 million at the expiry spot rate) to our counterparties and received $967 million from our counterparties. In 2023, foreign currency contracts with an aggregate notional value of €750 million expired.
See Notes 10 and 22 to the Consolidated Financial Statements for additional information. In 2025, foreign currency contracts with an aggregate notional value of €750 million expired. Upon settlement of these foreign currency contracts, we paid €750 million ($877 million at the expiry spot rate) to our counterparties and received $843 million from our counterparties.
Results for each of our business segments are discussed further in the Segment Analysis section below. Gain on Sale of Business —In the second quarter of 2024, we completed the sale of our Ethylene Oxide & Derivatives (“EO&D”) business and associated production facilities located in Bayport, Texas and recognized a pre-tax gain of $284 million.
Gain (Loss) on Sale of Business —In the second quarter of 2024, we completed the sale of our Ethylene Oxide & Derivatives (“EO&D”) business and associated production facilities located in Bayport, Texas and recognized a pre-tax gain of $284 million. See Note 9 to the Consolidated Financial Statements for additional information.
The decrease in Inventories was primarily driven by higher sales volumes, slightly offset by inventory build in anticipation of turnarounds in the first quarter of 2025. The decrease in Accounts payable was driven by decreased raw material costs, partially offset by timing of payments.
Decreased Accounts receivable of $127 million was primarily driven by lower average sales prices coupled with timing of sales and customer payments. The decrease of $25 million in Inventories was primarily driven by higher sales volumes, slightly offset by inventory build in anticipation of turnarounds in the first quarter of 2025.
For additional detail regarding these debt transactions see Note 11 to the Consolidated Financial Statements. In 2023, we made net repayments of $200 million through the issuance and repurchase of commercial paper instruments under our commercial paper program. In 2024, foreign currency contracts with an aggregate notional value of €784 million expired.
For additional detail regarding these debt transactions see Note 13 to the Consolidated Financial Statements. In 2024, foreign currency contracts with an aggregate notional value of €784 million expired.
EBITDA —EBITDA decreased by $982 million in 2024 compared to 2023. The decrease in EBITDA was largely driven by an $837 million non-cash impairment of property, plant and equipment related to our European assets included in our strategic review.
During 2024, we recognized an $837 million non-cash impairment of property, plant and equipment related to our European assets included in our strategic review.
During 2024, we generated $3,819 million in cash from operating activities, invested $1,839 million in capital expenditures and returned $1,915 million to shareholders through dividend payments and share repurchases. 35 Table of Conten ts Results of operations for the periods discussed are presented in the table below.
We invested $1.9 billion in capital expenditures and returned $2.0 billion to shareholders through dividend payments and share repurchases. 35 Table of Contents Results of operations for the periods discussed are presented in the table below.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 40,302 $ 41,107 Cost of sales 35,738 35,849 Impairments 949 518 Selling, general and administrative expenses 1,663 1,557 Research and development expenses 135 130 Operating income 1,817 3,053 Interest expense (481) (477) Interest income 150 129 Gain on sale of business 284 — Other income (expense), net 50 (58) Loss from equity investments (217) (20) Income from continuing operations before income taxes 1,603 2,627 Provision for income taxes 240 501 Income from continuing operations 1,363 2,126 Income (loss) from discontinued operations, net of tax 4 (5) Net income 1,367 2,121 Other comprehensive income (loss), net of tax – Financial derivatives 115 (80) Defined benefit pension and other postretirement benefit plans (2) (97) Foreign currency translations (169) 73 Total other comprehensive income (loss), net of tax (56) (104) Comprehensive income $ 1,311 $ 2,017 RESULTS OF OPERATIONS Revenues —Revenues decreased by $805 million, or 2%, in 2024 compared to 2023.
Year Ended December 31, Millions of dollars 2025 2024 2023 Sales and other operating revenues $ 30,153 $ 33,394 $ 33,336 Cost of sales 27,576 28,750 28,435 Goodwill impairments 972 — 252 Other impairments 279 949 255 Selling, general and administrative expenses 1,610 1,642 1,539 Research and development expenses 136 135 130 Operating income (loss) (420) 1,918 2,725 Interest expense (487) (481) (477) Interest income 97 150 129 Gain (loss) on sale of business (6) 284 — Other income (expense), net 113 47 (58) Loss from equity investments (12) (217) (20) Income (loss) from continuing operations before income taxes (715) 1,701 2,299 Provision for income taxes 70 259 433 Income (loss) from continuing operations (785) 1,442 1,866 Income (loss) from discontinued operations, net of tax 47 (75) 255 Net income (loss) (738) 1,367 2,121 Other comprehensive income (loss), net of tax— Financial derivatives (22) 115 (80) Defined benefit pension and other postretirement benefit plans 45 (2) (97) Foreign currency translations 199 (169) 73 Total other comprehensive income (loss), net of tax 222 (56) (104) Comprehensive income (loss) $ (516) $ 1,311 $ 2,017 RESULTS OF OPERATIONS Revenues —Revenues decreased by $3,241 million, or 10%, in 2025 compared to 2024.
For the market approach, since quoted market prices are usually not available, we utilize market multiples of revenue and earnings derived from comparable publicly traded industrial gases companies. During the fourth quarter of 2023, a trend of adverse financial performance triggered an impairment analysis of our investment in our European PO joint venture.
For the market approach, since quoted market prices are usually not available, we utilize market multiples of revenue and earnings derived from comparable publicly traded industrial gases companies.
As part of our overall capital allocation strategy, we plan to provide returns to shareholders in the form of dividends and share repurchases. Barring any significant or unforeseen business challenges, mergers or acquisitions, over the long-term, we are targeting shareholder returns of 70% of free cash flow, defined as net cash provided by operating activities less capital expenditures.
Over the long-term, we are targeting shareholder returns of 70% of free cash flow, defined as net cash provided by operating activities less capital expenditures; however, our returns may vary in the event of significant or unforeseen changes in business circumstances, mergers or acquisitions, or the continuation of the current downturn.
It is management’s responsibility, often with the assistance of independent experts, to select assumptions that in its judgment represent its best estimates of the future effects of those uncertainties and to review those assumptions periodically to reflect changes in economic or other factors.
It is our responsibility, often with the assistance of independent experts, to select assumptions that, in our judgment, represent its best estimates of the future effects of those uncertainties and to review those assumptions periodically to reflect changes in economic or other factors. 49 Table of Contents The current benefit service costs, as well as the existing liabilities, for pensions and other post-retirement benefits are measured on a discounted present value basis.
The benefit obligation and the net periodic benefit cost of other post-retirement medical benefits are also measured based on assumed rates of future increase in the per capita cost of covered health care benefits. As of December 31, 2024, the assumed rate of increase for our U.S. plans was 6.5%, decreasing to 4.5% in 2033 and thereafter.
The discount rates in effect at December 31, 2025 will be used to measure net periodic benefit cost during 2026. The benefit obligation and the net periodic benefit cost of other post-retirement medical benefits are also measured based on assumed rates of future increase in the per capita cost of covered health care benefits.
Our assumed discount rate is based on yield information for high-quality corporate bonds with durations comparable to the expected cash settlement of our obligations. For the purpose of measuring the benefit obligations at December 31, 2024, we used a weighted average discount rate of 5.35% for the U.S. plans, which reflects the different terms of the related benefit obligations.
The discount rate is a current rate, related to the rate at which the liabilities could be settled. Our assumed discount rate is based on yield information for high-quality corporate bonds with durations comparable to the expected cash settlement of our obligations.
Under the quantitative impairment test, the fair value of each reporting unit, calculated using a discounted cash flow model, is compared to its carrying value, including goodwill. The discounted cash flow model inherently utilizes a significant number of estimates and assumptions, including operating margins, tax rates, discount rates, capital expenditures and working capital changes.
Under the quantitative impairment test, the fair value of each reporting unit, calculated using an income approach such as a discounted cash flow model, is compared to its carrying value, including goodwill.
Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”).
Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”). In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 3,634 $ 3,698 Loss from equity investments — (1) EBITDA 54 (162) Revenues —Revenues decreased in 2024 by $64 million, or 2%, compared to 2023 as a result of lower average sales prices.
Year Ended December 31, Millions of dollars 2025 2024 Sales and other operating revenues $ 9,069 $ 10,424 Income (loss) from equity investments 3 (13) EBITDA 878 1,664 Revenues —Revenues decreased by $1,355 million, or 13%, in 2025 compared to 2024.
We estimate incurring one-time costs of $200 million in 2025 related to our Value Enhancement Program. RELATED PARTY TRANSACTIONS We have related party transactions with our joint ventures. We believe that such transactions are affected on terms substantially no more or less favorable than those that would have been agreed upon by unrelated parties on an arm’s length basis.
We believe that such transactions are affected on terms substantially no more or less favorable than those that would have been agreed upon by unrelated parties on an arm’s length basis. See Note 6 to the Consolidated Financial Statements for additional related party disclosures. 51 Table of Contents
Credit Arrangements At December 31, 2024, we had total debt, including current maturities, of $11,149 million. Additionally, we had $174 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.
There are currently no legal or economic restrictions that would materially impede our transfers of cash. Credit Arrangements At December 31, 2025, we had total debt, including current maturities, of $12,938 million. Additionally, we had $169 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.
ACCOUNTING AND REPORTING CHANGES For a discussion of the potential impact of new accounting pronouncements on our Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements. 52 Table of Conten ts
ACCOUNTING AND REPORTING CHANGES For a discussion of the potential impact of new accounting pronouncements on our Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements. CURRENT BUSINESS OUTLOOK During the first quarter of 2026, we are managing continued volatility in feedstock and energy prices.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 11,533 $ 11,280 Income from equity investments 13 49 EBITDA 2,445 2,303 Revenues —Revenues increased by $253 million, or 2%, in 2024 compared to 2023. Higher average sales prices across most of our products resulted in a 5% increase in revenue.
Year Ended December 31, Millions of dollars 2025 2024 Sales and other operating revenues $ 9,801 $ 11,533 Income from equity investments 37 13 EBITDA 1,144 2,445 Revenues —Revenues decreased by $1,732 million, or 15%, in 2025 compared to 2024.
Year Ended December 31, Millions of dollars 2024 2023 Sales and other operating revenues $ 10,867 $ 10,479 Loss from equity investments (217) (55) EBITDA (991) (9) Revenues —Revenues increased by $388 million, or 4%, in 2024 compared to 2023. Higher average sales prices and volumes each resulted in a 2% increase in revenue primarily due to higher demand.
Year Ended December 31, Millions of dollars 2025 2024 Sales and other operating revenues $ 10,227 $ 10,867 Loss from equity investments (52) (217) EBITDA (457) (991) Revenues —Revenues decreased by $640 million, or 6%, in 2025 compared to 2024.
Repurchased shares could be retired or used for general corporate purposes, including for various employee benefit and compensation plans. The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased. In 2024, we purchased 2.2 million shares under our share repurchase authorization for $198 million.
In 2025, we purchased approximately 3.0 million shares under our share repurchase authorization for $201 million. 46 Table of Contents The maximum number of shares that may yet be purchased is not necessarily an indication of the number of shares that will ultimately be purchased.
For additional information related to our share repurchase authorizations, see Note 18 to the Consolidated Financial Statements. Capital Budget In 2025, we are planning to invest approximately $1.9 billion in capital expenditures. Approximately $1.2 billion of the 2025 budget is planned for sustaining maintenance, with the remaining budget supporting profit-generating growth projects.
In September 2025, we amended our Senior Revolving Credit Facility which now restricts share repurchases, except to offset dilution. For additional information related to our share repurchase authorizations, see Note 20 to the Consolidated Financial Statements. Capital Budget In 2026, we are planning to invest approximately $1.2 billion in capital expenditures.
The weighted average discount rate used to measure obligations for non-U.S. plans at December 31, 2024, was 3.66%, reflecting market interest rates. The discount rates in effect at December 31, 2024 will be used to measure net periodic benefit cost during 2025.
For the purpose of measuring the benefit obligations at December 31, 2025, we used a weighted average discount rate of 5.43% for the U.S. plans, which reflects the different terms of the related benefit obligations. The weighted average discount rate used to measure obligations for non-U.S. plans at December 31, 2025, was 4.37%, reflecting market interest rates.
Cash provided by operating activities of $4,942 million in 2023 primarily reflected earnings adjusted for non-cash items and cash provided by the main components of working capital. In 2023, the main components of working capital provided $269 million of cash driven by a decrease in Accounts receivable and an increase in Accounts payable.
The decrease of $945 million in Inventories was primarily driven by our cash improvement plan actions. Cash provided by operating activities of $3,819 million in 2024 primarily reflected earnings adjusted for non-cash items and cash activities primarily related to Accounts receivable, Inventories, and Accounts payable.
Lower catalyst volumes driven by lower demand resulted in a 4% decrease in EBITDA. 43 Table of Conten ts FINANCIAL CONDITION The following table summarizes operating, investing and financing cash flow activities: Year Ended December 31, Millions of dollars 2024 2023 Cash provided by (used in): Operating activities $ 3,819 $ 4,942 Investing activities (1,853) (1,777) Financing activities (1,895) (1,950) Operating Activities —Cash provided by operating activities of $3,819 million in 2024 primarily reflected earnings adjusted for non-cash items and cash used by the main components of working capital–Accounts receivable, Inventories and Accounts payable.
FINANCIAL CONDITION The following table summarizes operating, investing and financing cash flow activities: Year Ended December 31, Millions of dollars 2025 2024 Cash provided by (used in): Operating activities $ 2,262 $ 3,819 Investing activities (1,776) (1,853) Financing activities (507) (1,895) Operating Activities —Cash provided by operating activities of $2,262 million in 2025 primarily reflected net loss adjusted for non-cash items, $393 million of tax payments which includes $235 million in U.S.